Примери за използване на Combination with dabrafenib на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Combination with dabrafenib.
Trametinib in combination with dabrafenib.
Rhabdomyolysis has been reported in patients taking trametinib alone or in combination with dabrafenib.
It is used in combination with dabrafenib.
Trametinib has been reported to decrease LVEF when used as monotherapy or in combination with dabrafenib.
Take Mekinist in combination with dabrafenib exactly as your doctor, nurse or pharmacist tells you.
Men taking trametinib in combination with dabrafenib.
Cases of cuSCC(including keratoacanthoma) have been reported in patients treated with trametinib in combination with dabrafenib.
Trametinib in combination with dabrafenib in patients with brain metastases.
Trametinib dose* Only when used in combination with dabrafenib.
When trametinib is used in combination with dabrafenib see sections 4.4 and 4.5 of the dabrafenib SmPC for interactions.
How should you take Mekinist in combination with dabrafenib.
Before you take Mekinist in combination with dabrafenib your doctor needs to know if you.
New primary melanoma was reported in patients receiving trametinib in combination with dabrafenib.
Mekinist as monotherapy or in combination with dabrafenib can cause rash or acne-like rash.
Dose adjustment for trametinib below 1 mg once daily is not recommended,when used in combination with dabrafenib.
Some people taking Mekinist in combination with dabrafenib may also notice that new melanomas have appeared.
The recommended dose of trametinib,either used as monotherapy or in combination with dabrafenib, is 2 mg once daily.
When trametinib is used in combination with dabrafenib please refer to the dabrafenib SmPC(section 4.4).
No dose modification of trametinib is required when taken in combination with dabrafenib(see section 4.4).
Patients treated with trametinib or combination with dabrafenib may develop ILD or pneumonitis.
No dose modification of dabrafenib is required when trametinib is taken in combination with dabrafenib.
The recommended dose of trametinib,when used in combination with dabrafenib, is 2 mg once daily.
Please refer to trametinib SmPC for information on method of administration when given in combination with dabrafenib.
No dose modification of trametinib is required when taken in combination with dabrafenib following diagnosis of uveitis.
Hepatic adverse reactions have been reported in clinical trials with trametinib as monotherapy and in combination with dabrafenib.
Pancreatitis has been reported in patients treated with trametinib in combination with dabrafenib in clinical trials.
No dose modification of trametinib is required for RAS mutation positive malignancies when taken in combination with dabrafenib.
Trametinib has been reported to decrease LVEF,when used as monotherapy or in combination with dabrafenib(see section 4.8).
In clinical trials uveitis andiridocyclitis have also been reported in patients treated with trametinib in combination with dabrafenib.